SOPHiA GENETICS SOPH Insider Ownership

Updated Oct 8, 2026

Over the past year, SOPH insiders bought $99,000 of stock (20K shares) and sold $5.05 million (817.36K shares) on the open market.

• By number of insiders, SOPHiA Genetics saw one insider buy and 10 insiders sell on the open market over the past 12 months.
• Among SOPHiA Genetics' insiders, George Cardoza (Chief Financial Officer) was the largest open-market buyer over the past 12 months, purchasing $99,000 of stock (20K shares), most recently on June 5, 2026.
• Conversely, Jurgi Camblong (Executive Chairman) was SOPH's largest open-market seller in the past 12 months, with $2.67 million of sales (442.89K shares); the latest was on October 5, 2026.
• Beyond open-market trades, insiders at SOPHiA Genetics received 871.88K shares in stock awards and acquired 120K shares through option exercises and conversions in the last 12 months.
• Per Business Quant, SOPH insiders together hold 7.36Mn shares based on their latest Form 4 filings, down 5.04% from 7.75Mn shares at the end of Q2 2026.
• None of the 7.36Mn shares held by SOPHiA Genetics insiders is held through trusts, partnerships or family members; all are direct holdings.
• The insider holdings in SOPHiA Genetics belong to 14 insiders who have reported on Form 4 within the past two years.
• SOPHiA Genetics' three biggest insider holders are Jurgi Camblong (Executive Chairman, 3.4Mn shares), Ross Muken (Chief Executive Officer, 660.39K shares) and Zhenyu Xu (Chief Scientific Officer, 545.49K shares), based on their latest Form 4 filings.
• Jurgi Camblong holds 46.15% of the combined insider position in SOPHiA Genetics.
• Institutions accounted for 54.22% of SOPH's outstanding shares in Q2 2026.
• In the past year, 14 insiders of SOPHiA Genetics submitted 131 Form 4 filings reporting trades, awards or other transactions.
• The insider holdings and trades above for SOPHiA Genetics reflect Form 4 filings through October 7, 2026.